Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
ARA-290 Synonyms / Designations: ARA-290, Cibinetide, Helix B Surface Peptide (HBSP), Erythropoietin-derived peptide CAS Number: 1208243-50-8 Molecular Formula: C51H84N16O21 Molar Weight: 1257.3 g/mol Peptide Sequence: Derived from the helix B region of erythropoietin (EPO) Peptide Classification: Synthetic peptide analogue
When Peptides Alone Are Enough Peptides may be the best option when a patient has: Mild to moderate injuries Good overall healing capacity Early signs of inflammation or soft-tissue strain A preference for lower-cost, non-interventional options When Stem Cell or Biologic Therapy Is More Appropriate Biologic therapies may be recommended when a patient has: Advanced arthritis Significant cartilage or tendon damage Chronic pain that hasnt responded to conservative treatment Long-standing degeneration that needs more structural support Combining Therapies for Better Outcomes In many cases, the strongest outcomes come from sequencing both treatments strategically
Investigated for effects on appetite regulation, energy expenditure, and insulin sensitivity
Most people tolerate L-carnitine well
Lactobacillus and Bifidobacterium are the strains that have the most evidence to support their use, and theyre unlikely to cause side effects, says Richardson
US$ 22.48
US$ 26.63
US$ 25.37
US$ 24.20
